4.965PLN-0.70%Mkt Cap: 74.80M PLNP/E: —Last update: 2026-06-01
Genomtec S.A. researches and develops a mobile point of care genetic testing platform for the clinical diagnostics market in Poland. The company's flagship project is the Genomtec ID, a diagnostic platform that offer mob…
Industry Peers
Medical Devices152.01BUSDP/E 24.4
115.59BUSDP/E 34.9
71.08BUSDP/E 20.0
54.41BSEKP/E 101.6
52.05BDKKP/E 22.0
51.03BUSDP/E 47.9
50.55BSEKP/E 21.4
38.34BEURP/E 18.1
Indicators:|
Key Statistics
Company
Market Cap74.80M PLN
Enterprise Value70.05M PLN
Revenue (TTM)15.00K PLN
Gross Profit1.00K PLN
Net Income (TTM)-11.21M PLN
Revenue/Share0.0010 PLN
Last Price4.965 PLN
Fiscal Year EndDec 2024
MR QuarterSep 2025
Employees26
CountryPL
SectorHealthcare
IndustryMedical Devices
ISINPLGNMTC00017
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-8.69
EV/Revenue4670.08
P/S5021.54
P/B7.28
EPS (TTM)-0.75
EPS (Forward)—
52W Range
3.24542% of range7.350
52W High7.350 PLN
52W Low3.245 PLN
Profitability
Gross Margin100.00%
Oper. Margin-62850.00%
EBITDA Margin0.00%
Profit Margin-1120800.00%
ROE-147.47%
ROA-65.77%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-6.72M PLN
CapEx (TTM)59.00K PLN
FCF Margin-29065.83%
FCF Yield-5.83%
Net Debt-5.27M PLN
Net Debt/EBITDA0.65
Balance Sheet
Debt/Equity0.36
Current Ratio2.82
Quick Ratio2.48
Book Value/Sh0.6870 PLN
Cash/Share0.4910 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.15.06M
Float12.06M
Insiders8.01%
Institutions10.00%
Technical
SMA 505.050 (-1.7%)
SMA 2005.226 (-5.0%)
Beta0.29
S&P 52W Chg27.94%
Avg Vol (30d)65.00K
Avg Vol (10d)63.26K
Technical Indicators
RSI (14)40.9
MACD0.0723
MACD Signal0.2048
MACD Hist.-0.1325
BB Upper6.700 PLN
BB Middle5.564 PLN
BB Lower4.427 PLN
BB Width40.87%
ATR (14)0.3978 PLN
Vol Ratio (20d)0.70x